| Parkinson’s disease is associated with altered expression of CaV1 channels and calcium-binding proteins MJ Hurley, B Brandon, SM Gentleman, DT Dexter Brain 136 (7), 2077-2097, 2013 | 203 | 2013 |
| What has been learnt from study of dopamine receptors in Parkinson's disease? MJ Hurley, P Jenner Pharmacology & therapeutics 111 (3), 715-728, 2006 | 165 | 2006 |
| Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain MJ Hurley, DC Mash, P Jenner Journal of neural transmission 110, 1279-1288, 2003 | 125 | 2003 |
| Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR MJ Hurley, DC Mash, P Jenner European Journal of Neuroscience 18 (9), 2668-2672, 2003 | 113 | 2003 |
| NNZ-2566, a novel analog of (1–3) IGF-1, as a potential therapeutic agent for fragile X syndrome RMJ Deacon, L Glass, M Snape, MJ Hurley, FJ Altimiras, RR Biekofsky, ... Neuromolecular medicine 17, 71-82, 2015 | 83 | 2015 |
| Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson’s disease MJ Hurley, DC Mash, P Jenner Molecular brain research 87 (2), 271-279, 2001 | 73 | 2001 |
| D3 receptor expression within the basal ganglia is not affected by Parkinson's disease MJ Hurley, CM Stubbs, P Jenner, CD Marsden Neuroscience letters 214 (2-3), 75-78, 1996 | 69 | 1996 |
| Voltage-gated calcium channels and Parkinson's disease MJ Hurley, DT Dexter Pharmacology & therapeutics 133 (3), 324-333, 2012 | 63 | 2012 |
| Dopamine D3 receptors in the basal ganglia of the common marmoset and following MPTP and L-DOPA treatment MJ Hurley, J Jolkkonen, CM Stubbs, P Jenner, CD Marsden Brain research 709 (2), 259-264, 1996 | 59 | 1996 |
| Adenosine A2A receptor mRNA expression in Parkinson's disease MJ Hurley, DC Mash, P Jenner Neuroscience letters 291 (1), 54-58, 2000 | 56 | 2000 |
| Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP‐treated common marmosets MJ Hurley, MJ Jackson, LA Smith, S Rose, P Jenner European Journal of Neuroscience 21 (12), 3240-3250, 2005 | 52 | 2005 |
| Calcium channel antagonists as disease-modifying therapy for Parkinson’s disease: therapeutic rationale and current status T Swart, MJ Hurley Cns Drugs 30, 1127-1135, 2016 | 40 | 2016 |
| Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain MJ Hurley, CM Stubbs, P Jenner, CD Marsden Psychopharmacology 128, 362-370, 1996 | 39 | 1996 |
| Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical … MJ Hurley, CM Stubbs, P Jenner, CD Marsden European journal of pharmacology 318 (2-3), 283-293, 1996 | 35 | 1996 |
| The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases MJ Hurley, RMJ Deacon, K Beyer, E Ioannou, A Ibáñez, JL Teeling, ... Pharmacology & therapeutics 188, 36-44, 2018 | 33 | 2018 |
| Altered expression of brain proteinase-activated receptor-2, trypsin-2 and serpin proteinase inhibitors in Parkinson’s disease MJ Hurley, PF Durrenberger, SM Gentleman, AF Walls, DT Dexter Journal of Molecular Neuroscience 57, 48-62, 2015 | 32 | 2015 |
| Bile acids and neurological disease MJ Hurley, R Bates, J Macnaughtan, AHV Schapira Pharmacology & therapeutics 240, 108311, 2022 | 28 | 2022 |
| Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization MJ Hurley, SM Gentleman, DT Dexter Journal of Molecular Neuroscience 55, 715-724, 2015 | 25 | 2015 |
| Altered gut microbiota in a fragile X syndrome mouse model F Altimiras, JA Garcia, I Palacios-García, MJ Hurley, R Deacon, ... Frontiers in Neuroscience 15, 653120, 2021 | 20 | 2021 |
| Brain transcriptome sequencing of a natural model of Alzheimer's disease F Altimiras, B Uszczynska-Ratajczak, F Camara, A Vlasova, E Palumbo, ... Frontiers in Aging Neuroscience 9, 64, 2017 | 15 | 2017 |
